BANK OF MONTREAL /CAN/ - CONTRAVIR PHARMACEUTICALS IN ownership

CONTRAVIR PHARMACEUTICALS IN's ticker is CTRVXXXX and the CUSIP is 21234W103. A total of 31 filers reported holding CONTRAVIR PHARMACEUTICALS IN in Q3 2017. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
BANK OF MONTREAL /CAN/ ownership history of CONTRAVIR PHARMACEUTICALS IN
ValueSharesWeighting
Q1 2018$12,000
-33.3%
50,0000.0%0.00%
Q4 2017$18,000
-30.8%
50,0000.0%0.00%
Q3 2017$26,000
-43.5%
50,000
-37.5%
0.00%
Q2 2017$46,000
-67.6%
80,0000.0%0.00%
Q1 2017$142,000
-10.1%
80,0000.0%0.00%
Q4 2016$158,000
+393.8%
80,000
+166.7%
0.00%
Q3 2016$32,000
+3.2%
30,0000.0%0.00%
Q2 2016$31,000
-13.9%
30,0000.0%0.00%
Q1 2016$36,000
+140.0%
30,000
+200.0%
0.00%
Q4 2015$15,00010,0000.00%
Other shareholders
CONTRAVIR PHARMACEUTICALS IN shareholders Q3 2017
NameSharesValueWeighting ↓
Prospera Financial Services Inc 167,600$126,0000.02%
HighTower Advisors, LLC 1,037,871$540,0000.01%
MCIA Inc 5,300$3,0000.00%
TWO SIGMA SECURITIES, LLC 51,190$27,0000.00%
Virtu Financial LLC 31,902$17,0000.00%
INGALLS & SNYDER LLC 20,739$11,0000.00%
BDO Wealth Advisors, LLC 3,000$2,0000.00%
Perigon Wealth Management, LLC 9$00.00%
Balentine LLC 55$00.00%
Capital Advisors, Ltd. LLC 177$00.00%
View complete list of CONTRAVIR PHARMACEUTICALS IN shareholders